News & Events

FET FLAGSHIP Proposal on Personalized Health Care Initiative

More News

World TERMIS 2021

After Seoul, Vienna, and Boston, Maastricht was selected to host the next world conference of the tissue engineering and regenerative medicine society. We expect to attract more than 2'000 delegates by 2021 in Maastricht, which is at the center of a European region fervidly active in tissue engineering, regenerative medicine, stem cells, biomaterials, in silico modeling, and biofabrication.

Read More

Biofabrication for the eardrum

Tympanic membrane (or eardrum) is provided by nature with unique anatomic features that ultimately allow a superb physiologic performance in varying frequency ranges. Several pathologies damage this tissue, including chronic otitis media (COM), which ultimately bring to deafness.

Read More

Biofabrication with dynamic materials

3D printing makes it possible to create complex personalized products such as prostheses and implants directly from a 3D scan. To make this type of application possible, it is important that available materials have the correct mechanical and biochemical properties. In the TA program DYNAM, which is funded from the Innovation Fund for Chemistry, researchers and companies will tackle this challenge

Read More

New Project on 3D printing

Damaged and diseased bones in the region of head, face and jaws are common, and are conventionally treated using metallic or polymeric implants, which poorly bond to the surrounding bone. As a result, failure of such implants is common.

Read More

Podcast on Biofabrication

Prof. Moroni was interviewed by Future Tech Podcast on Biofabrication and its promise for regenerative medicine and pharmaceutical applications as 3D in vitro models.

Read More

FET FLAGSHIP Proposal on Personalized Health Care Initiative
Published on: February 6, 2018
Category: Group Activities

The proposal is coordinated by the University of Minho, and is supported by a Steering Committee of 15 members, including Maastricht University, representing academia and industry leaders from across Europe. It is also supported by a large number of organisations, including over 140 academia and health institutes, 40 research institutes, 95 industry and associations and 25 regional and national authorities.

Through a multi-actor and multi-disciplinary approach, the initiative will focus on the development of targeted and specific therapies for diseases that have an impact on society and the patient, the development of new technologies, and preventive and predictive tools.

FET Flagships are one of the most prestigious, highly-funded, strongest and game-changing instruments of EU research. They will involve a total budget of about €1 billion including EU and public and private funding.

 

For more information and to show your support, please visit the Personalised Health Care Initiative website: http://web.spi.pt/fetflagship-personalisedhealthcare/

https://www.maastrichtuniversity.nl/news/um-partner-fet-flagship-proposal-personalised-health-care